Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma

This study has been terminated.
(early stopping rule)
Sponsor:
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01374217
First received: June 13, 2011
Last updated: March 23, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2015
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)